ARTICLE | Emerging Company Profile

BioMetrx: RASS restoration

BioMetrx developing plant-derived Rasstore to reduce prostate cancer growth

March 26, 2012 7:00 AM UTC

BioMetrx LLC has early data for its Rasstore suggesting that restoring levels of the tumor suppressor gene RASSF1A may lead to superior safety and efficacy compared to current prostate cancer therapies.

Rasstore selectively inhibits an isoform of DNA methyltransferase, which in turn leads to up-regulation of Ras association domain family 1A (RASSF1A). BioMetrx believes up-regulation of RASSF1A prevents tumor growth...